Dosage and administration
Apply daily as a lip moisturizer and protector for dryness, cold sores, or fever blisters. To achieve best results, apply at the first sign of symptoms (dryness, cracking) directly on the lip and affected area as needed.
Apply daily as a lip moisturizer and protector for dryness, cold sores, or fever blisters. To achieve best results, apply at the first sign of symptoms (dryness, cracking) directly on the lip and affected area as needed.
Active ingredient Purpose
Zinc Oxide (0.015%) Cold Sores & Fever blisters
Cocoa Butter(0.25%) Cold Sores & Fever blisters
Treatment for cold sores and fever blisters, a vesicle that occurs at the junction of the mucous membrane and the skin on the lips or nose and is caused by the virus herpes simplex, type 1.
If condition worsens or does not improve after regular use of the product as directed, consult a doctor.
If swallowed, contact a doctor.
For external use only.
Apply daily as a lip moisturizer and protector for dryness, cold sores, or fever blisters. To achieve best results, apply at the first sign of symptoms (dryness, cracking) directly on the lip and affected area as needed.
During an outbreak, also use AverTeaX Topical Ointment for temporary relief of pain and itching.
Do not use if allergic to any ingredient of the product.
If condition worsens or does not improve after regular use of the product as directed, consult a doctor. If swallowed, contact a doctor.
Indications are for relief of dryness, cold sores and fever blisters.
For relief of dryness, soften cold sores and fever blisters.
If allergic to any ingredient of the product.
Bees Wax, Shea Butter, Sweet Almond Oil, Vitamin E, Grape Seed Extract, Aloe Vera Extract, Royal Jelly, EGCG (Epigallocatechin-3-Gallate, Extracted from Green Tea) Stearate, EGCG Palmitate, Eucalyptus oil.
AVERTEAX DAILY LIP PROTECTOR FOR DRYNESS, COLD SORES & FEVER BLISTERS DISTRIBUTED BY CAMELLIX MADE IN USA
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1536212 | Averteax Lip Protector (cocoa butter 0.25 % / Zinc Oxide 0.15 % ) Topical Cream | PSN | 1 |
| 1536207 | cocoa butter 0.25 % / zinc oxide 0.015 % Topical Cream | PSN | 1 |
| 1536212 | cocoa butter 2.5 MG/ML / zinc oxide 0.15 MG/ML Topical Cream [Averteax Lip Protector] | SBD | 1 |
| 1536207 | cocoa butter 2.5 MG/ML / zinc oxide 0.15 MG/ML Topical Cream | SCD | 1 |
| 1536212 | Averteax Lip Protector (cocoa butter 0.25 % / Zinc Oxide 0.15 % ) Topical Cream | SY | 1 |
| 1536207 | cocoa butter 2.5 MG/ML / ZNO 0.15 MG/ML Topical Cream | SY | 1 |
| 1536212 | cocoa butter 2.5 MG/ML / ZNO 0.15 MG/ML Topical Cream [Averteax Lip Protector] | SY | 1 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54866-001-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-44e2-60a7-e053-dbdaa90a05bd | AVERTEX Zinc Oxide, Cocoa Butter |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54866-001-01 | AVERTEAX | 4.2 g in 1 TUBE | CREAM | 4.2 | 1 | |
| 54866-001-01 | AVERTEAX | 1 in 1 PACKAGE | CREAM | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| COCOA BUTTER | ACTIVE INGREDIENT | 512OYT1CRR | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| COCOA BUTTER | ACTIVE MOIETY | 512OYT1CRR | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| ALMOND OIL | INACTIVE INGREDIENT | 66YXD4DKO9 | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| EPIGALLOCATECHIN GALLATE PALMITATES | INACTIVE INGREDIENT | M213AC47MB | 1 | |
| EPIGALLOCATECHIN GALLATE STEARATES | INACTIVE INGREDIENT | MGB2NQG22C | 1 | |
| EUCALYPTUS OIL | INACTIVE INGREDIENT | 2R04ONI662 | 1 | |
| Royal Jelly | INACTIVE INGREDIENT | L497I37F0C | 1 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| VITIS VINIFERA SEED | INACTIVE INGREDIENT | C34U15ICXA | 1 | |
| YELLOW WAX | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54866-001 | 54866-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
| COCOA BUTTER | 512OYT1CRR | ACTIB |
| YELLOW WAX | 2ZA36H0S2V | IACT |
| SHEA BUTTER | K49155WL9Y | IACT |
| ALMOND OIL | 66YXD4DKO9 | IACT |
| .ALPHA.-TOCOPHEROL | H4N855PNZ1 | IACT |
| VITIS VINIFERA SEED | C34U15ICXA | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| Royal Jelly | L497I37F0C | IACT |
| EPIGALLOCATECHIN GALLATE STEARATES | MGB2NQG22C | IACT |
| EPIGALLOCATECHIN GALLATE PALMITATES | M213AC47MB | IACT |
| EUCALYPTUS OIL | 2R04ONI662 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | CAPSULE / ORAL | 16 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, SUGAR COATED / ORAL | NA | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CAPSULE / ORAL | 44 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | FILM, SOLUBLE / BUCCAL | 0.07 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CREAM / TOPICAL | 5 %w/w | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, DELAYED RELEASE / ORAL | 0.1 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SOLUTION / ORAL | 1.05 mg/1ml | ||
| EUCALYPTUS OIL | EUCALYPTUS OIL | 2R04ONI662 | SYRUP / ORAL | NA | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET / ORAL | 3.22 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CAPSULE, EXTENDED RELEASE / ORAL | 80.67 mg | ||
| ALMOND OIL | ALMOND OIL | 66YXD4DKO9 | CREAM / TOPICAL | 2 %w/w | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET / ORAL | 2 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, FILM COATED / ORAL | 246 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | OINTMENT / TOPICAL | 20 %w/w | ||
| SHEA BUTTER | SHEA BUTTER | K49155WL9Y | LOTION / TOPICAL | 2340 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, CHEWABLE / ORAL | 0.1 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, COATED / ORAL | 213.7 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.64 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 274fa9e5-6f94-4ac3-b952-0a7fdeebad45 | 1e5ea5fd-4394-4b7c-bcbc-6c443d1135d7 | 2014-03-07 | Warnings | 274fa9e5-6f94-4ac3-b952-0a7fdeebad45 1e5ea5fd-4394-4b7c-bcbc-6c443d1135d7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.